Futura Medical (LON:FUM) Stock Price Down 12.4% – Here’s What Happened

Futura Medical plc (LON:FUM) was down 12.4% on Friday. The stock traded as low as GBX 0.18 and last traded at GBX 0.18. 31,148,195 shares changed hands during mid-day trading, an increase of 195% from the average session volume of 10,547,822 shares. The stock had previously closed at GBX 0.21.

Futura Medical Stock Down 12.4%

The firm has a fifty day moving average of GBX 0.29 and a 200-day moving average of GBX 0.57. The stock has a market capitalization of £2.73 million, a price-to-earnings ratio of -0.23 and a beta of 0.02.

Futura Medical (LON:FUM) last released its quarterly earnings results on Tuesday, September 1st. The company reported GBX (0.20) EPS for the quarter. Futura Medical had a negative net margin of 158.21% and a negative return on equity of 152.42%. As a group, research analysts forecast that Futura Medical plc will post 2.85 EPS for the current fiscal year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.